4g16
From Proteopedia
(Difference between revisions)
| Line 21: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 4g16" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4g16" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Casein kinase|Casein kinase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 30: | Line 27: | ||
[[Category: Human]] | [[Category: Human]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
| - | [[Category: Huang | + | [[Category: Huang, X]] |
[[Category: Ck1g]] | [[Category: Ck1g]] | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Kinase]] | [[Category: Kinase]] | ||
[[Category: Transferase-transferase inhibitor complex]] | [[Category: Transferase-transferase inhibitor complex]] | ||
Revision as of 19:56, 24 January 2018
Crystal structure of ck1g3 with 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2-YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE
| |||||||||||
